IMMUNOPOIESIS-MODULATING PROPERTIES OF BIOFLAVONOIDES ORIGINAL COMPLEX «EPIGENORM ANTIVIR»
- Authors: Goldina I.A.1, Markova E.V.1,2, Orlovskaya I.A.1, Toporkova L.B.1
-
Affiliations:
- Federal state budgetary scientific institution “Scientific research institute of fundamental and clinical immunology”
- Federal State Budgetary Educational Institution of Higher Education “Novosibirsk State Pedagogical University»
- Issue: Vol 22, No 3 (2019)
- Pages: 1118-1124
- Section: ORIGINAL ARTICLES
- Submitted: 25.08.2020
- Accepted: 25.08.2020
- Published: 15.10.2019
- URL: https://rusimmun.ru/jour/article/view/487
- DOI: https://doi.org/10.31857/S102872210007237-5
- ID: 487
Cite item
Full Text
Abstract
About the authors
I. A. Goldina
Federal state budgetary scientific institution “Scientific research institute of fundamental and clinical immunology”
Author for correspondence.
Email: iigoldina@mail.ru
researcher of the Neuroimmunology laboratory,
Novosibirsk
Russian FederationE. V. Markova
Federal state budgetary scientific institution “Scientific research institute of fundamental and clinical immunology”;Federal State Budgetary Educational Institution of Higher Education “Novosibirsk State Pedagogical University»
Email: fake@neicon.ru
Head of the Neuroimmunology laboratory, chief researcher;
professor,
Novosibirsk
Russian FederationI. A. Orlovskaya
Federal state budgetary scientific institution “Scientific research institute of fundamental and clinical immunology”
Email: fake@neicon.ru
MD, Professor, head of the Stem cell immunobiology laboratory,
Novosibirsk
Russian FederationL. B. Toporkova
Federal state budgetary scientific institution “Scientific research institute of fundamental and clinical immunology”
Email: fake@neicon.ru
PhD, senior scientifi c researcher of the Stem cell immunobiology laboratory,
Novosibirsk
Russian FederationReferences
- Ohm J. E., Carbone D. P. VEGF as a mediator of tumor-associated immunodeficiency. Immunol. Res. 2001, 23(2–3), 263–72.
- Weissman I. L. Stem cells: Units of development, units of regeneration, and units in evolution. Cell 2000, 100, 157–168.
- Wei Q., Frenette P. S. Niches for hematopoietic stem cells and their progeny. Immunity 2018, 48, 632–648.
- Attari F., Zahmatkesh M., Aligholi H., Mehr S. E., Sharifzadeh M., Gorji A., Mokhtari T., Khaksarian M., Hassanzadeh G. Curcumin as a double-edged sword for stem cells: dose, time and cell type-specifi c responses to curcumin. Daru 2015, 23, 33. doi: 10.1186/s40199- 015-0115-8.
- Гайдуль К. В., Гольдина И. А., Сафронова И. В. Исследование морфометрических параметров органов иммунной системы под действием нутрицевтика эпигеном-направленного действия на фоне экспериментальной гемодепрессии. Журнал научных статей «Здоровье и образование в XXI веке» 2018, 20, (10), 10–13. dx.doi.org/10.26787/nydha2226-7425-2018-20-10-10-13.
- Гольдина И. А., Гайдуль К. В. Биологическая активность и терапевтические свойства Curcuma Longa L. (Обзор литературы) Вестник Новосибирского государственного университета. Серия: Биология, клиническая медицина 2015, 13(1), 106–114.
- Гольдина И. А., Маркова Е. В., Гольдин Б. Г., Княжева М. А., Гайдуль К. В. Протекторные свойства экстракта куркумы при этанолиндуцированных нарушениях поведения. Саратовский научномедицинский журнал 2017, 13(1), 131–135.
- Любимов Г. Ю., Гольдина И. А., Гайдуль К. В., Козлов В. А. Противоопухолевые свойства экстракта корневищ Curcuma Longa L. в глицерине на модели роста экспериментальной меланомы мышей В16. Сибирский научный медицинский журнал 2016, 36(4), 56–60.
- Piao L., Mukherjee S., Chang Q., Xie X., Li H., Castellanos M. R., Banerjee P., Iqbal H., Ivancic R., Wang X., Teknos T. N., Pan Q. TriCurin, a novel formulation of curcumin, epicatechin gallate and resveratrol, inhibits the tumorigenicity of human papillomavirus-positive head and neck squamous cell carcinoma. Oncotarget. 2016, 8(36), 60025–60035. doi: 10.18632/oncotarget.10620. doi: 10.18632/oncotarget.10620.
- Душкин А. В., Гайдуль К. В., Гольдина И. А., Гуськов С. А., Евсеенко В. И., Ляхов Н. З., Козлов В. А. Антимикробная активность механохимически синтезированных композитов антибиотиков и наноструктурированного диоксида кремния. Доклады АН 2012, 443(1), 120–122.
- Lin S. Y., Kang L., Wang C. Z., Huang H. H., Cheng T. L., Huang H. T., Chen C. H. (–)-Epigallocatechin-3-Gallate (EGCG) Enhances Osteogenic Differentiation of Human Bone Marrow Mesenchymal Stem Cells. Molecules (Basel, Switzerland) 2018, 23(12), 3221. doi: 10.3390/molecules23123221.
- Drapeau C., Benson K. F., Jensen G. S. Rapid and selective mobilization of specific stem cell types after consumption of a polyphenol-rich extract from sea buckthorn berries (Hippophae) in healthy human subjects. Clinical interventions in aging 2019 14, 253–263. doi: 10.2147/CIA.S186893.
- Chen X., Zhi X., Yin Z., Li X., Qin L., Qiu Z., Su J. 18β-Glycyrrhetinic Acid Inhibits Osteoclastogenesis In Vivo and In Vitro by Blocking RANKL–Mediated RANK-TRAF6 Interactions and NF-κB and MAPK Signaling Pathways. Frontiers in pharmacology 2018, 9, 647. doi: 10.3389/fphar.2018.00647.
- Vishvakarma N. K., Kumar A., Kant S, Bharti A. C., Singh S. M. Myelopotentiating effect of curcumin in tumor-bearing host: role of bone marrow resident macrophages. Toxicol. Appl. Pharmacol. 2012, 263(1), 111–21. doi: 10.1016/j.taap.2012.06.004.
- Fu Z., Chen X., Guan S., Yan Y., Lin H., Hua Z.-C. Curcumin inhibits angiogenesis and improves defective hematopoiesis induced by tumor-derived VEGF in tumor model through modulating VEGF-VEGFR2 signaling pathway. Oncotarget 2015, 6(23), 19469–19482. doi: 10.18632/oncotarget.3625.
- Chen X., Wang J., Fu Z., Zhu B., Wang J., Guan S., Hua Z. Curcumin activates DNA repair pathway in bone marrow to improve carboplatin-induced myelosuppression. Scientifi c Reports 2017, 7, 17724. doi: 10.1038/s41598-017-16436-9.
- Mohammadi S., Ghaffari S. H., Shaiegan M., Zarif M. N., Nikbakht M., Akbari Birgani S., Alimoghadam K., Ghavamzadeh A. Acquired expression of osteopontin selectively promotes enrichment of leukemia stem cells through AKT/mTOR/PTEN/beta-catenin pathways in AML cells. Life Sci. 2016b, 152, 190–198.